Amicus Therapeutics to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010

Tuesday, January 5, 2010 Press Release
Email Print This Page Comment bookmark
Font : A-A+

CRANBURY, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that  President and Chief

Executive Officer, John F. Crowley, will be presenting an overview of the Company's key strategic priorities for 2010 at the upcoming 28th Annual J.P. Morgan Healthcare Conference.  Mr. Crowley's presentation is scheduled
to begin on Monday, January 11 at 10:30 a.m. PST.

Individuals can listen to a live webcast of the presentation by logging on to the Investors section of the Amicus Therapeutics' web site, http://www.amicustherapeutics.com.  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's Web site for 30 days.

About Amicus Therapeutics

Amicus Therapeutics is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration.  Amicus' lead program is in Phase 3 for the treatment of Fabry disease. 

SOURCE Amicus Therapeutics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook